The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Functional genomic screens and identification of signaling pathways in oxaliplatin-resistance in colorectal cancer.
Niharika B. Mettu
No relevant relationships to disclose
Joshua M. Uronis
No relevant relationships to disclose
Takuya Osada
No relevant relationships to disclose
Min Lu
No relevant relationships to disclose
Koya Osada
No relevant relationships to disclose
Robert Mook
No relevant relationships to disclose
Wei Chen
No relevant relationships to disclose
Michael Morse
No relevant relationships to disclose
H. Kim Lyerly
No relevant relationships to disclose
Kris Wood
No relevant relationships to disclose
Shiaowen David Hsu
No relevant relationships to disclose